Efficacy of Carbonic Anhydrase in Patients with X-Linked Retinoschisis episode artwork

EPISODE · Jun 6, 2024 · 20 MIN

Efficacy of Carbonic Anhydrase in Patients with X-Linked Retinoschisis

from Ophthalmology Journal

X-linked retinoschisis is a relatively common inherited retinal degenerative disease that almost exclusively affects males. No curative medical therapy is available for this condition, however topical and oral carbonic anhydrase inhibitors have been used  for the management of cystoid fluid collections. Dr. Drew Carey interviews authors Dr. Jonathan Hensman and Dr. Camiel J.F. Boon on the results of their Ophthalmology Retina article, "Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis." Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis. Hensman, Jonathan et al. Ophthalmology Retina. In press The Ophthalmology-family of journals is now on Instagram. Follow aaojournal for clinical images, research articles, news, editorials, podcasts, and more! Sign up for the next Ophthalmology Journal Virtual Club on June 19, 2024, at https://store.aao.org/ophthalmology-virtual-journal-club.html

Episode metadata supplied by the publisher feed · Published Jun 6, 2024

Embed this episode

Ready to play

Efficacy of Carbonic Anhydrase in Patients with X-Linked Retinoschisis

0:00 20:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Ophthalmology Journal?

This episode is 20 minutes long.

When was this Ophthalmology Journal episode published?

This episode was published on June 6, 2024.

Can I download this Ophthalmology Journal episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!